Evidence map›Paper›PMID 42328278›Full record

ArticleReproductive medicine and biology

The Impact of Leukemia Inhibitory Factor on

Seyed Mohammad Seifati, Fateme Zare, Hossein Ansariniya, Farzaneh Fesahat, Samaneh Harimi, Maryam Imani, Hossein Hadinedoushan

Abstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seyed Mohammad SeifatiReproductive Immunology Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID https://orcid.org/0000-0002-0340-5455
Fateme ZareReproductive Immunology Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID https://orcid.org/0000-0003-0436-9924
Hossein AnsariniyaReproductive Immunology Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID https://orcid.org/0000-0002-5731-4612
Farzaneh FesahatReproductive Immunology Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID https://orcid.org/0000-0002-3743-4449
Samaneh HarimiReproductive Immunology Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran.
Maryam ImaniReproductive Immunology Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran.
Hossein HadinedoushanReproductive Immunology Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Leukemia Inhibitory Factor (LIF) plays a crucial role in implantation and early pregnancy maintenance. However, its regulatory relationships with molecular markers such as Sirtuin 1 (SIRT1), immunoglobulin-like transcript 4 (ILT-4), and specific microRNAs (miRNA) in recurrent pregnancy loss (RPL) remain underexplored. Methods: This study investigates the effect of LIF on the expression of Results: The LIF-treated group showed significant upregulation of Conclusions: These results suggest that LIF modulates critical molecular pathways in RPL by influencing the expression of essential genes and miRNAs, highlighting its potential as a therapeutic target for pregnancy-related complications.

Indexed as

ILT‐4leukemia inhibitory factormicroRNAsrecurrent pregnancy losssirtuin 1

Identifiers

PMID42328278
PMCPMC13279882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.